While pancreatitis is rare, it can occur at any dose level, particularly in individuals with personal or family history of pancreatic disease
Retatrutide is an investigational triple-receptor agonist developed by Eli Lilly
In T2DM, agents such as semaglutide and tirzepatide effectively lower HbA1c levels, blood glucose levels, and body weight, outperforming conventional oral hypoglycemic agents and insulin
We also offer compounded semaglutide injections for as little as $40 per week, which makes it affordable and attainable for everyone, even out-of-pocket for when insurance cant cover it
GLP-1 in Endometriosis has become a growing topic of interest as medications like Ozempic, Wegovy, and Mounjaro transform endocrine and metabolic care
Why Two Different Receptors Matter GHSR-1a and GHRHR are pharmacologically distinct